Functional multispectral optoacoustic tomography imaging of hepatic steatosis development in mice.
EMBO Mol. Med. 13:e13490 (2021)
The increasing worldwide prevalence of obesity, fatty liver diseases and the emerging understanding of the important roles lipids play in various other diseases is generating significant interest in lipid research. Lipid visualization in particular can play a critical role in understanding functional relations in lipid metabolism. We investigated the potential of multispectral optoacoustic tomography (MSOT) as a novel modality to non-invasively visualize lipids in laboratory mice around the 930nm spectral range. Using an obesity-induced non-alcoholic fatty liver disease (NAFLD) mouse model, we examined whether MSOT could detect and differentiate different grades of hepatic steatosis and monitor the accumulation of lipids in the liver quantitatively over time, without the use of contrast agents, i.e. in label-free mode. Moreover, we demonstrate the efficacy of using the real-time clearance kinetics of indocyanine green (ICG) in the liver, monitored by MSOT, as a biomarker to evaluate the organ’s function and assess the severity of NAFLD. This study establishes MSOT as an efficient imaging tool for lipid visualization in preclinical studies, particularly for the assessment of NAFLD.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Biomarker ; Icg ; Lipid Metabolism ; Nafld ; Optoacoustic Imaging; Indocyanine Green Clearance; Liver Fat; In-vivo; Nafld
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
1757-4676
e-ISSN
1757-4684
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 13,
Heft: 9,
Seiten: ,
Artikelnummer: e13490
Supplement: ,
Reihe
Verlag
Wiley
Verlagsort
Chichester
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
30201 - Metabolic Health
30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er)
Enabling and Novel Technologies
Genetics and Epidemiology
Helmholtz Diabetes Center
PSP-Element(e)
G-505500-001
G-500600-001
A-630600-001
G-500390-001
G-502390-001
Förderungen
Projekt DEAL
Helmholtz-Gemeinschaft Deutscher Forschungszentren (HGF)/ExNet project "Innovative Intelligent Imaging" (i3-Helmholtz)
European Research Council (ERC) under the European Union
Deutsche Forschungsgemeinschaft (DFG), Germany
Copyright
Erfassungsdatum
2021-09-21